I'm LongbridgeAI, I can summarize articles.In Wednesday's pre-market session, several healthcare stocks showed significant volatility. Gainers included IM Cannabis (+56.3%), Vistagen Therapeutics (+55.92%), and Decoy Therapeutics (+36.45%). Conversely, major losers featured Jaguar Health (-47.9%), Profusa (-16.13%), and Henry Schein (-14.11%). These movements reflect early trading activity across various market capitalizations within the healthcare sector.
Gainers
- IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market session. The company's market cap stands at $2.5 million.
- Vistagen Therapeutics (NASDAQ:VTGN) shares increased by 55.92% to $0.39. The market value of their outstanding shares is at $11.1 million.
- Decoy Therapeutics (NASDAQ:DCOY) stock rose 36.45% to $4.23. The market value of their outstanding shares is at $2.0 million.
- Greenland Mines (NASDAQ:GRML) stock rose 26.5% to $17.9. The company's market cap stands at $44.9 million.
- Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved upwards by 20.06% to $0.72. The market value of their outstanding shares is at $11.1 million.
- Advanced Biomed (NASDAQ:ADVB) shares rose 13.63% to $7.25. The company's market cap stands at $10.4 million.
Losers
- Jaguar Health (NASDAQ:JAGX) shares declined by 47.9% to $17.95 during Wednesday's pre-market session. The company's market cap stands at $17.9 million.
- Profusa (NASDAQ:PFSA) stock declined by 16.13% to $1.82. The market value of their outstanding shares is at $1.3 million.
- Gelteq (NASDAQ:GELS) shares decreased by 14.46% to $0.52. The company's market cap stands at $6.5 million.
- Henry Schein (NASDAQ:HSIC) stock declined by 14.11% to $75.1. The market value of their outstanding shares is at $10.9 billion.
- Silexion Therapeutics (NASDAQ:SLXN) stock declined by 10.79% to $0.35. The company's market cap stands at $2.1 million.
- BGM Group (NASDAQ:BGM) stock fell 9.85% to $0.23. The market value of their outstanding shares is at $103.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock927characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.